70 likes | 449 Views
Updated ASRA Guidelines (2010). No POC validation of platelet function ASA ( alone ) no increased risk Thienopyridines additive with aspirin There is no wholly accepted test, including the bleeding time, which will guide antiplatelet therapy
E N D
Updated ASRA Guidelines (2010) • No POC validation of platelet function • ASA (alone) no increased risk • Thienopyridines additive with aspirin • There is no wholly accepted test, including the bleeding time, which will guide antiplatelet therapy • The ACCP recommends discontinuation of clopidogrel for 7 to 10 days, whereas in patients at high risk for recurrent angina, 5 days has been suggested Horlocker et al: RegAnesthPain Med;2010:35:64-101